UK Markets open in 5 hrs 41 mins
NIKKEI 225
28,378.95 +559.62 (+2.01%) HANG SENG
20,082.43 0.00 (0.00%) CRUDE OIL
93.96 -0.38 (-0.40%) GOLD FUTURES
1,803.40 -3.80 (-0.21%) DOW
33,336.67 +27.17 (+0.08%) BTC-GBP
19,644.10 -255.23 (-1.28%)
MaxCyte, Inc. (MXCT.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 06:26PM BST
| Previous close | 445.00 |
| Open | 440.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 440.00 - 489.00 |
| 52-week range | 280.00 - 1,235.00 |
| Volume | |
| Avg. volume | 45,827 |
| Market cap | 484.709M |
| Beta (5Y monthly) | 1.23 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -14.80 |
| Earnings date | 18 Apr 2022 - 22 Apr 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 9.78 |
- Motley Fool
MaxCyte, Inc. (MXCT) Q2 2022 Earnings Call Transcript
Good day, and thank you for standing by, and welcome to MaxCyte second quarter 2022 earnings conference call. My name is Sean Menarguez, and I'm the director of investor relations here at MaxCyte. On the call from MaxCyte, we have Doug Doerfler, president and chief executive officer; and Ron Holtz, interim chief financial officer.
- Zacks
MaxCyte, Inc. (MXCT) Reports Q2 Loss, Tops Revenue Estimates
MaxCyte, Inc. (MXCT) delivered earnings and revenue surprises of 0% and 6.76%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
© 2022 Yahoo. All rights reserved.
